Ayurvedic Herbs Targeting Cell Cycle Checkpoints in Cancer
DOI:
https://doi.org/10.47070/ijapr.v14i10.4478Keywords:
Ayurvedic Medicinal Plants, Cell-Cycle Checkpoints, Cancer Biology, Phytochemicals, Cyclin-Dependent Kinases, Molecular OncologyAbstract
Malfunctioning cyclin-dependent kinases, defects in the DNA damage response, and aberrations in mitotic checkpoints maintain unregulated proliferation, a hallmark of cancer. Ayurvedic medicinal plants contain various chemical constituents that may act on these pathways. The biological impact of altered cell cycle status varies across experimental models. This critical narrative review evaluates studies published from 2020 to 2025 on the potential impact of curcumin from Curcuma longa, withaferin A from Withania somnifera, nimbolide from Azadirachta indica, andrographolide from Andrographis paniculata, and preparations from Ocimum tenuiflorum, Tinospora cordifolia, Boswellia serrata, and Phyllanthus emblica on cell cycle and checkpoint regulation. Studies have reported effects of curcumin on S-phase, withaferin A and andrographolide on G2/M phase arrest and nimbolide on DNA damage or ER stress. Protein expression changes or cytotoxicity, and in silico docking do not indicate checkpoint engagement. Genetic validation of cell-cycle checkpoint regulators for these natural products remains limited. Most of the evidence is from studies using cancer cell lines and/or animals. Other limitations, such as compositional heterogeneity, extract exposure and selectivity, and reproducibility, also apply to these studies. Given the current preclinical evidence, some Ayurvedic compounds may be pharmacologically useful for cancer, and warrant further study in the context of efficacy, safety and targeted cancer therapy.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2026 International Journal of Ayurveda and Pharma Research

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

